The lawsuit, filed by two former Medtronic employees, named 120 spine surgeons and 18 medical device distributors as defendants. The suit alleged that the defendants took a total of $8 million in consulting fees, advising “off-label” use of the Medtronic product, Infuse.
The federal judge ruled that the case did not constitute a whistle-blower suit and blocked an amended complaint by the defendant. Despite this ruling, a civil suit is still active in federal court.
Read about the dismissed Medtronic/spine surgeon lawsuit.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.